Replies to post #4003 on Generex Biotechnology Corp. (fka GNBTQ)

[veeets]

I still like our chances on this upside vs 3 cents downward. The 4 to 5 years is the general biotech platform company conservative endgame estimate. If a partner for us comes, it has to come soon and that will move the stock. $150m partner is not that difficult especially if the data is anything good. The US Army and affiliated medical resources is a plus. There is also accelerated FDA fast track along the way if we have the goods. AE needs a partner and India finally needs to happen with Oralyn and hopefully a partner with that program too. I hate that the execs have all this free stock but its worthless for them also if the Co goes bellyup.